Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


We studied the mechanism of lymphocytic choriomeningitis virus (LCMV) persistence and the suppression of cytotoxic T lymphocyte (CTL) responses in BALB/c WEHI mice infected at birth with LCMV Armstrong strain. Using adoptive transfer experiments we found that spleen cells from persistently infected (carrier) mice actively suppressed the expected LCMV-specific CTL response of spleen cells from normal adult mice. The suppression was specific for the CTL response and LCMV -specific antibody responses were not affected. Associated with the specific CTL suppression was the establishment of persistent LCMV infection. The transfer of spleen or lymph node cells containing LCMV -specific CTL resulted in virus clearance and prevented establishment of the carrier state. The suppression of LCMV -specific CTL responses by carrier spleen cells is not mediated by a suppressor cell, but is due to the presence of genetic variants of LCMV in spleens of carrier mice. Such virus variants selectively suppress LCMV-specific CTL responses and cause persistent infections in immunocompetent mice. In striking contrast, wild-type LCMV Armstrong, from which these variants were generated, induces a potent CTL response in immunocompetent mice and the LCMV infection is rapidly cleared. Our results show that LCMV variants that emerge during infection in vivo play a crucial role in the suppression of virus-specific CTL responses and in the maintenance of virus persistence.

Free full text 


Logo of jexpmedLink to Publisher's site
J Exp Med. 1984 Aug 1; 160(2): 521–540.
PMCID: PMC2187458
PMID: 6332167

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

Abstract

We studied the mechanism of lymphocytic choriomeningitis virus (LCMV) persistence and the suppression of cytotoxic T lymphocyte (CTL) responses in BALB/c WEHI mice infected at birth with LCMV Armstrong strain. Using adoptive transfer experiments we found that spleen cells from persistently infected (carrier) mice actively suppressed the expected LCMV-specific CTL response of spleen cells from normal adult mice. The suppression was specific for the CTL response and LCMV - specific antibody responses were not affected. Associated with the specific CTL suppression was the establishment of persistent LCMV infection. The transfer of spleen or lymph node cells containing LCMV - specific CTL resulted in virus clearance and prevented establishment of the carrier state. The suppression of LCMV -specific CTL responses by carrier spleen cells is not mediated by a suppressor cell, but is due to the presence of genetic variants of LCMV in spleens of carrier mice. Such virus variants selectively suppress LCMV-specific CTL responses and cause persistent infections in immunocompetent mice. In striking contrast, wild-type LCMV Armstrong, from which these variants were generated, induces a potent CTL response in immunocompetent mice and the LCMV infection is rapidly cleared. Our results show that LCMV variants that emerge during infection in vivo play a crucial role in the suppression of virus-specific CTL responses and in the maintenance of virus persistence.

Full Text

The Full Text of this article is available as a PDF (1.3M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fuccillo DA, Kurent JE, Sever JL. Slow virus diseases. Annu Rev Microbiol. 1974;28(0):231–234. [Abstract] [Google Scholar]
  • Marion PL, Robinson WS. Hepadna viruses: hepatitis B and related viruses. Curr Top Microbiol Immunol. 1983;105:99–121. [Abstract] [Google Scholar]
  • Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MB. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol. 1980;30:275–331. [Abstract] [Google Scholar]
  • Oldstone MB, Dixon FJ. Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science. 1967 Dec 1;158(3805):1193–1195. [Abstract] [Google Scholar]
  • Benson L, Hotchin J. Antibody formation in persistent tolerant infection with lymphocytic choriomeningitis virus. Nature. 1969 Jun 14;222(5198):1045–1047. [Abstract] [Google Scholar]
  • Marker O, Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med. 1973 Jun 1;137(6):1511–1525. [Europe PMC free article] [Abstract] [Google Scholar]
  • Traub E. PERSISTENCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN IMMUNE ANIMALS AND ITS RELATION TO IMMUNITY. J Exp Med. 1936 May 31;63(6):847–861. [Europe PMC free article] [Abstract] [Google Scholar]
  • Dutko FJ, Oldstone MB. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J Gen Virol. 1983 Aug;64(Pt 8):1689–1698. [Abstract] [Google Scholar]
  • Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology. 1981 Aug;113(1):73–85. [Abstract] [Google Scholar]
  • Zinkernagel RM, Welsh RM. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol. 1976 Nov;117(5 Pt 1):1495–1502. [Abstract] [Google Scholar]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [Abstract] [Google Scholar]
  • Cihak J, Lehmann-Grube F. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology. 1978 Feb;34(2):265–275. [Abstract] [Google Scholar]
  • Dunlop MB, Blanden RV. Mechanisms of suppression of cytotoxic T-cell responses in murine lymphocytic choriomeningitis virus infection. J Exp Med. 1977 May 1;145(5):1131–1143. [Europe PMC free article] [Abstract] [Google Scholar]
  • Mims CA, Blanden RV. Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus. Infect Immun. 1972 Nov;6(5):695–698. [Europe PMC free article] [Abstract] [Google Scholar]
  • Hotchin J, Kinch W, Benson L. Lytic and turbid plaque-type mutants of lymphocytic choriomeningitis virus as a cause of neurological disease or persistent infection. Infect Immun. 1971 Sep;4(3):281–286. [Europe PMC free article] [Abstract] [Google Scholar]
  • Popescu M, Lehmann-Grube F. Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse. J Gen Virol. 1976 Jan;30(1):113–122. [Abstract] [Google Scholar]
  • Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science. 1982 Mar 26;215(4540):1577–1585. [Abstract] [Google Scholar]
  • Ahmed R, Chakraborty PR, Fields BN. Genetic variation during lytic reovirus infection: high-passage stocks of wild-type reovirus contain temperature-sensitive mutants. J Virol. 1980 Apr;34(1):285–287. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kono Y, Kobayashi K, Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch Gesamte Virusforsch. 1973;41(1):1–10. [Abstract] [Google Scholar]
  • Narayan O, Griffin DE, Chase J. Antigenic shift of visna virus in persistently infected sheep. Science. 1977 Jul 22;197(4301):376–378. [Abstract] [Google Scholar]
  • Cole GA, Nathanson N, Prendergast RA. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 1972 Aug 11;238(5363):335–337. [Abstract] [Google Scholar]
  • Doherty PC, Dunlop MB, Parish CR, Zinkernagel RM. Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol. 1976 Jul;117(1):187–190. [Abstract] [Google Scholar]
  • Ahmed R, Canning WM, Kauffman RS, Sharpe AH, Hallum JV, Fields BN. Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell. 1981 Aug;25(2):325–332. [Abstract] [Google Scholar]
  • Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. [Abstract] [Google Scholar]
  • Pfau CJ, Valenti JK, Pevear DC, Hunt KD. Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections. J Exp Med. 1982 Jul 1;156(1):79–89. [Europe PMC free article] [Abstract] [Google Scholar]
  • Oldstone MB, Sinha YN, Blount P, Tishon A, Rodriguez M, von Wedel R, Lampert PW. Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science. 1982 Dec 10;218(4577):1125–1127. [Abstract] [Google Scholar]
  • Fink PJ, Weissman IL, Bevan MJ. Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med. 1983 Jan 1;157(1):141–154. [Europe PMC free article] [Abstract] [Google Scholar]
  • Rammensee HG, Nagy ZA, Klein J. Suppression of cell-mediated lymphocytotoxicity against minor histocompatibility antigens mediated by Lyt-1+Lyt-2+ T cells of stimulator-strain origin. Eur J Immunol. 1982 Nov;12(11):930–934. [Abstract] [Google Scholar]
  • Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med. 1983 May 1;157(5):1434–1447. [Europe PMC free article] [Abstract] [Google Scholar]
  • Lehmann-Grube F, Cihak J, Varho M, Tijerina R. The immune response of the mouse to lymphocytic choriomeningitis virus. II. Active suppression of cell-mediated immunity by infection with high virus doses. J Gen Virol. 1982 Feb;58(Pt 2):223–235. [Abstract] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/43369577
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/43369577

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1084/jem.160.2.521

Supporting
Mentioning
Contrasting
13
793
0

Article citations


Go to all (527) article citations

Funding 


Funders who supported this work.

NIAID NIH HHS (1)

NINDS NIH HHS (1)